ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
First Wave BioPharma to continue Covid-19 GI infection therapy trial Pharmaceutical-Technology
December 02, 2021An independent data monitoring committee (DMC) has recommended First Wave BioPharma to continue enrolment for the second part of its ongoing RESERVOIR Phase II trial of FW-COV to treat gastrointestinal (GI) infections related to Covid-19.
Pharma Sources Insight January 2025
